Antibody data
- Antibody Data
- Antigen structure
- References [4]
- Comments [0]
- Validations
- Western blot [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- HPA014711 - Provider product page
- Provider
- Atlas Antibodies
- Proper citation
- Atlas Antibodies Cat#HPA014711, RRID:AB_1848147
- Product name
- Anti-EMP2
- Antibody type
- Polyclonal
- Description
- Polyclonal Antibody against Human EMP2, Gene description: epithelial membrane protein 2, Alternative Gene Names: XMP, Validated applications: WB, ICC, IHC, Uniprot ID: P54851, Storage: Store at +4°C for short term storage. Long time storage is recommended at -20°C.
- Reactivity
- Human
- Host
- Rabbit
- Conjugate
- Unconjugated
- Isotype
- IgG
- Vial size
- 100 µl
- Concentration
- 0.2 mg/ml
- Storage
- Store at +4°C for short term storage. Long time storage is recommended at -20°C.
- Handling
- The antibody solution should be gently mixed before use.
Submitted references The cAMP responsive element binding protein 1 transactivates epithelial membrane protein 2, a potential tumor suppressor in the urinary bladder urothelial carcinoma
The Novel Human Influenza A(H7N9) Virus Is Naturally Adapted to Efficient Growth in Human Lung Tissue
Influenza A Viruses Target Type II Pneumocytes in the Human Lung
Loss of epithelial membrane protein-2 expression confers an independent prognosticator in nasopharyngeal carcinoma: a cohort study
Li C, Wu W, Wu W, Liao Y, Chen L, Huang C, Li C, Li W, Huang H, Chen Y, Liang S, Chow N, Shiue Y
Oncotarget 2015;6(11):9220-9239
Oncotarget 2015;6(11):9220-9239
The Novel Human Influenza A(H7N9) Virus Is Naturally Adapted to Efficient Growth in Human Lung Tissue
Knepper J, Schierhorn K, Becher A, Budt M, Tönnies M, Bauer T, Schneider P, Neudecker J, Rückert J, Gruber A, Suttorp N, Schweiger B, Hippenstiel S, Hocke A, Wolff T, Palese P
mBio 2013;4(5)
mBio 2013;4(5)
Influenza A Viruses Target Type II Pneumocytes in the Human Lung
Weinheimer V, Becher A, Tonnies M, Holland G, Knepper J, Bauer T, Schneider P, Neudecker J, Ruckert J, Szymanski K, Temmesfeld-Wollbrueck B, Gruber A, Bannert N, Suttorp N, Hippenstiel S, Wolff T, Hocke A
Journal of Infectious Diseases 2012;206(11):1685-1694
Journal of Infectious Diseases 2012;206(11):1685-1694
Loss of epithelial membrane protein-2 expression confers an independent prognosticator in nasopharyngeal carcinoma: a cohort study
Chen Y, Wu L, Wu W, Lin H, Lee S, Lin C, Chang S, Chow N, Huang H, Li C, Hsu H, Shiue Y
BMJ Open 2012;2(2):e000900
BMJ Open 2012;2(2):e000900
No comments: Submit comment
Enhanced validation
- Submitted by
- Atlas Antibodies (provider)
- Enhanced method
- Recombinant expression validation
- Main image
- Experimental details
- Western blot analysis in control (vector only transfected HEK293T lysate) and EMP2 over-expression lysate (Co-expressed with a C-terminal myc-DDK tag (~3.1 kDa) in mammalian HEK293T cells, LY400553).
- Sample type
- Human
- Protocol
- Protocol